Ribavirin-induced pure red-cell aplasia during treatment of chronic hepatitis C

N Engl J Med. 2004 Mar 18;350(12):1264-5. doi: 10.1056/NEJM200403183501222.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antiviral Agents / adverse effects*
  • Antiviral Agents / therapeutic use
  • Drug Therapy, Combination
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Male
  • Middle Aged
  • Recombinant Proteins
  • Red-Cell Aplasia, Pure / chemically induced*
  • Ribavirin / adverse effects*
  • Ribavirin / therapeutic use

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Ribavirin